Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016–2017

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Rathi, Priya ; Shringarpure, Kalpita ; Unnikrishnan, Bhaskaran ; Chadha, Vineet Kumar ; Acharya, Vishak ; Nair, Abirami ; Sagili, Karuna D. ; Shastri, Suresh
• Description:
  In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.
• Subjects:
  Antitubercular Agents Health Expenditures Humans Income Mycobacterium Tuberculosis Tuberculosis Tuberculosis, Multidrug-Resistant
• Source:
  Emerg Infect Dis. 26(5):989-992
• Pubmed ID:
  32310069
• Pubmed Central ID:
  PMC7181943
• Document Type:
  Journal Article
• Place as Subject:
  India
• Volume:
  26
• Issue:
  5
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:7f9c3a31a9fcbcaf09a7e5bca1f6878f958d7a900dc164b8a4525520c7ca6146
• Download URL:
  https://stacks.cdc.gov/view/cdc/87647/cdc_87647_DS1.pdf
• File Type:
  [PDF - 434.80 KB ]